CDMRP: Spinal Cord Injury (SCI) Research Program

FY22 Focus Areas:

• Preserving and protecting spinal cord tissue at time of injury for improved neurologic outcomes
• Identifying and validating biomarkers for diagnosis, prognosis, and for evaluation of treatment efficacies
• Developing, testing, & validating promising interventions to address bowel, genitourinary, neuropathic pain, cardiopulmonary, or autonomic dysfunction in people with SCI
• Investigating psychosocial issues relevant to people with SCI, their families, and/or their care-partners
• Rehabilitation and regeneration—maximizing the function of the residual neural circuitry, including harnessing neuroplasticity & recovery to improve function after SCI

Award Mechanisms:

• Clinical Trial Award: Funds the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of SCI.  Funding: up to $3.1M over 4 years.
• Translational Research Award: Funds studies that accelerate the movement of promising ideas in SCI research into clinical applications.  Funding: up to $1.35M over 3 years.
• Investigator-Initiated Research Award: Funds research that has the potential to make an important contribution to SCI research, patient care, and/or quality of life.  Funding: up to $0.6M over 3 years.

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=431101

https://ebrap.org/eBRAP/public/ViewFileTemplate.htm?fileTemplateId=10381293&fileType=pdf